MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY, AUTOSOMAL DOMINANT
|
disease |
|
Finding
|
1
|
5
|
0.100 |
None |
|
0 |
5
|
|
|
Hypoglycemic coma
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
19
|
|
0.100 |
None |
|
0 |
|
|
|
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY, AUTOSOMAL RECESSIVE
|
disease |
|
Finding
|
1
|
3
|
0.100 |
None |
|
0 |
3
|
|
|
Exercise-induced muscle cramps
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Finding
|
8
|
1
|
0.100 |
None |
|
0 |
|
|
|
Islets of Langerhans hyperplasia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Feeding difficulties
|
phenotype |
|
Finding
|
473
|
62
|
0.100 |
None |
|
0 |
|
|
|
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.100 |
None |
|
0 |
|
|
|
Creatine phosphokinase serum increased
|
phenotype |
|
Finding
|
228
|
43
|
0.100 |
None |
|
0 |
|
|
|
Ketonuria
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
1
|
0.100 |
None |
|
0 |
|
|
|
Exercise-induced muscle fatigue
|
phenotype |
|
Finding
|
18
|
3
|
0.100 |
None |
|
0 |
|
|
|
Exercise-induced muscle stiffness
|
phenotype |
|
Finding
|
4
|
1
|
0.100 |
None |
|
0 |
|
|
|
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.100 |
None |
|
0 |
|
|
|
Ketotic hypoglycemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
15
|
1
|
0.100 |
None |
|
0 |
|
|
|
Hypoglycemic seizures
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
19
|
|
0.100 |
None |
|
0 |
|
|
|
Multiple Endocrine Neoplasia Type 2a
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
69
|
44
|
0.020 |
None |
1.000 |
2 |
|
1976 |
1978 |
Medullary carcinoma of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
330
|
71
|
0.010 |
None |
1.000 |
1 |
|
1978 |
1978 |
Parathyroid hyperplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
37
|
1
|
0.010 |
None |
1.000 |
1 |
|
1978 |
1978 |
Multiple endocrine neoplasia Type 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
56
|
38
|
0.010 |
None |
1.000 |
1 |
|
1978 |
1978 |
Familial medullary thyroid carcinoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
56
|
45
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
46 |
|
1996 |
2020 |
Erythrocyte Lactate Transporter Defect
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1
|
2
|
0.700 |
strong |
1.000 |
2 |
2
|
2000 |
2003 |
Carnitine-Acylcarnitine Translocase Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
7
|
16
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
CUI: |
C0010709 |
Disease: |
Cyst
|
Cyst
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Disease or Syndrome
|
221
|
6
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
31 |
|
2002 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
27 |
|
2002 |
2019 |